Source: Pharamceutical Technology

IDA: Chiltern buys IDA to integrate Japan and Asia into global drug development

Global contract research organisation (CRO) Chiltern has acquired Integrated Development Associates (IDA), a clinical research organisation (CRO) that focuses on integrating Japan and Asia into a global drug development.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
John Winebarger's photo - President & CEO of I D A

President & CEO

John Winebarger

CEO Approval Rating

70/100

Read more